

Publisher: Adis International
ISSN: 0114-9954
Source: Reactions Weekly, Vol.1, Iss.1187, 2008-01, pp. : 4-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Adalimumab/infliximab: Psoriasis: case report
Reactions Weekly, Vol. 1, Iss. 1350, 2011-01 ,pp. :


Adalimumab: Cutaneous leishmaniasis: case report
Reactions Weekly, Vol. 1, Iss. 1274, 2009-01 ,pp. :


Infliximab: Cutaneous leishmaniasis: case report
Reactions Weekly, Vol. 1, Iss. 1271, 2009-01 ,pp. :


Infliximab: Cutaneous leishmaniasis: case report
Reactions Weekly, Vol. 1, Iss. 1299, 2010-01 ,pp. :


Adalimumab/infliximab: Cutaneous sarcoidosis: 2 case reports
Reactions Weekly, Vol. 1, Iss. 1308, 2010-01 ,pp. :